|
Martínez E, Larrousse M, Podzamczer D, Pérez I, Gutiérrez F, Loncá M, Barragán P, Deulofeu R, Casamitjana R, Mallolas J, Pich J, Gatell JM; BICOMBO Study Team. Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction. AIDS. 2010 Jan 28;24(3):F1-9. doi: 10.1097/QAD.0b013e32833562c5. PubMed PMID: 20009917.
AÑO: 2010; IF: 5.003
|
20009917
|
Sobrino-Vegas P, García-San Miguel L, Caro-Murillo AM, Miró JM, Viciana P, Tural C, Saumoy M, Santos I, Sola J, del Amo J, Moreno S; CoRIS. Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality. Curr HIV Res. 2009 Mar;7(2):224-30. PubMed PMID: 19275591.
AÑO: 2009; IF: 1.612
|
|
Bernal E, Muñoz A, Ortiz Mdel M, Cano A. [Syphilitic panuveitis in an HIV-infected patient after immune restoration]. Enferm Infecc Microbiol Clin. 2009 Oct;27(8):487-9. doi: 10.1016/j.eimc.2008.12.008. Epub 2009 May 5. Spanish. PubMed PMID: 19406524.
AÑO: 2009; IF: 1.714
|
|
Mallolas J, Podzamczer D, Milinkovic A, Domingo P, Clotet B, Ribera E, Gutiérrez F, Knobel H, Cosin J, Ferrer E, Arranz JA, Roca V, Vidal F, Murillas J, Pich J, Pedrol E, Llibre JM, Dalmau D, García I, Aranda M, Cruceta A, Martínez E, Blanco JL, Lazzari Ed, Gatell JM; ATAZIP Study Group. Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a LPV/r-containing HAART: the ATAZIP study. J Acquir Immune Defic Syndr. 2009 May 1;51(1):29-36. doi: 10.1097/QAI.0b013e31819a226f. PubMed PMID: 19390327.
AÑO: 2009; IF: 3.935
|
|
Bernal E, Muñoz A, Núñez ML, Cano A. [An HIV-positive man with spontaneous development of a thyroid tumor]. Enferm Infecc Microbiol Clin. 2009 May;27(5):298-300. doi: 10.1016/j.eimc.2008.09.008. Spanish. PubMed PMID: 19386386.
AÑO: 2009; IF: 1.53
|